SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis.

Tuncay, Gülseren; Bostan, Ozge Can; Damadoglu, Ebru; Karakaya, Gül; Kalyoncu, Ali Fuat

Tuncay, Gülseren; Bostan, Ozge Can; Damadoglu, Ebru; Karakaya, Gül; Kalyoncu, Ali Fuat.

Tuncay G; Division of Allergy and Clinical Immunology, Faculty of Medicine, Hacettepe University, Ankara, Turkey. Electronic address: seren_tuncay@hotmail.com.
Bostan OC; Division of Allergy and Clinical Immunology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Damadoglu E; Division of Allergy and Clinical Immunology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Karakaya G; Division of Allergy and Clinical Immunology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Kalyoncu AF; Division of Allergy and Clinical Immunology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Ann Allergy Asthma Immunol ; 128(6): 733-734, 2022 06.

Article in English | MEDLINE | ID: covidwho-1783167

Subject(s)

COVID-19 Vaccines; COVID-19; Mastocytosis; COVID-19/prevention & control; Humans; Mastocytosis/complications; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mastocytosis / COVID-19 Vaccines / COVID-19 Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Ann Allergy Asthma Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google